Literature DB >> 15904927

Histopathological studies of experimental lyme disease in the dog.

B A Summers1, A F Straubinger, R H Jacobson, Y-F Chang, M J G Appel, R K Straubinger.   

Abstract

Experimental borrelia infection was induced in 62 specific--pathogen-free beagle dogs by exposure to Ixodes scapularis ticks harbouring the spirochaete Borrelia burgdorferi. Clinical signs of Lyme disease occurred in 39/62 dogs, the remaining 23 being subclinically infected. Clinical signs consisted of one to six episodes of transitory lameness with joint swelling and pain, most commonly affecting the elbow or shoulder joints. The polymerase chain reaction and culture demonstrated that the dogs remained infected for up to 581 days. At necropsy, gross findings consisted of lymphadenopathy in the area of tick attachment. Microscopical changes consisted of effusive fibrinosuppurative inflammation or nonsuppurative inflammation, or both, affecting synovial membranes, joint capsules and associated tendon sheaths. Plasma cells dominated areas of chronic inflammation, with CD3(+) T cells being present in lesser numbers. Microscopical signs of arthritis were polyarticular and more widespread than indicated by clinical signs, and most of the subclinically affected animals also had synovitis. In areas of tick attachment to the skin, hyperkeratosis and a mixture of suppurative and nonsuppurative dermatitis were encountered. Lymphadenopathy in superficial lymph nodes resulted from follicular and parafollicular hyperplasia. In 14/62 dogs, lymphoplasmacytic periarteritis and perineuritis were noted, resembling lesions found in human Lyme disease and syphilis, in which an underlying microangiopathy has been proposed.

Entities:  

Mesh:

Year:  2005        PMID: 15904927     DOI: 10.1016/j.jcpa.2004.11.006

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  23 in total

1.  Tick-borne Diseases (Borreliosis, Anaplasmosis, Babesiosis) in German and Austrian Dogs: Status quo and Review of Distribution, Transmission, Clinical Findings, Diagnostics and Prophylaxis.

Authors:  Nikola Pantchev; Silvia Pluta; Elke Huisinga; Stephanie Nather; Miriam Scheufelen; Majda Globokar Vrhovec; Andrea Schweinitz; Herwig Hampel; Reinhard K Straubinger
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

2.  Vaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme Disease.

Authors:  Rhonda L LaFleur; Steven M Callister; Jennifer C Dant; Terri L Wasmoen; Dean A Jobe; Steven D Lovrich
Journal:  Clin Vaccine Immunol       Date:  2015-05-13

3.  Lyme disease risk in dogs in New Brunswick.

Authors:  Natalie K Bjurman; Gina Bradet; Vett K Lloyd
Journal:  Can Vet J       Date:  2016-09       Impact factor: 1.008

4.  One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin.

Authors:  Rhonda L LaFleur; Steven M Callister; Jennifer C Dant; Dean A Jobe; Steven D Lovrich; Thomas F Warner; Terri L Wasmoen; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2010-03-17

5.  Antibodies to Borrelia burgdorferi OspA, OspC, OspF, and C6 antigens as markers for early and late infection in dogs.

Authors:  Bettina Wagner; Heather Freer; Alicia Rollins; David Garcia-Tapia; Hollis N Erb; Christopher Earnhart; Richard Marconi; Patrick Meeus
Journal:  Clin Vaccine Immunol       Date:  2012-02-15

6.  The amber theory of Lyme arthritis: initial description and clinical implications.

Authors:  Gary P Wormser; Robert B Nadelman; Ira Schwartz
Journal:  Clin Rheumatol       Date:  2012-03-13       Impact factor: 2.980

7.  Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.

Authors:  Rhonda L LaFleur; Jennifer C Dant; Terri L Wasmoen; Steven M Callister; Dean A Jobe; Steven D Lovrich; Thomas F Warner; O Abdelmagid; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

8.  Quantitative measurement of C6 antibody following antibiotic treatment of Borrelia burgdorferi antibody-positive nonclinical dogs.

Authors:  Steven A Levy; Thomas P O'Connor; Jancy L Hanscom; Paulette Shields; Leif Lorentzen; Anthony A Dimarco
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

9.  Detection of antibodies to decorin-binding protein A (DbpA) and DbpB after infection of dogs with Borrelia burgdorferi by tick challenge.

Authors:  Darby G Oldenburg; Dean A Jobe; Steven D Lovrich; Rhonda L LaFleur; Douglas W White; Jennifer C Dant; Steven M Callister
Journal:  J Vet Diagn Invest       Date:  2020-03-20       Impact factor: 1.279

10.  Follow-up of Bernese Mountain dogs and other dogs with serologically diagnosed Borrelia burgdorferi infection: what happens to seropositive animals?

Authors:  Bernhard Gerber; Katharina Haug; Simone Eichenberger; Claudia E Reusch; Max M Wittenbrink
Journal:  BMC Vet Res       Date:  2009-05-08       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.